GlassScriptPhysician profile
Kevin M Fleishman
NPI 1265414437
$64,584.83
in general payments reported to CMS, 2019-2025
45 companies · $2,032 in 2025
The $2,032 reported for 2025 was more than what 94% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,738 · 2020: $2,320 · 2021: $30K · 2022: $1,791 · 2023: $15K · 2024: $6,180 · 2025: $2,032.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $7,503 · Food and Beverage: $2,235 · Travel and Lodging: $877 · Education: $86.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,102.50 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $7,503.19 |
| Food and Beverage | $2,234.57 |
| Travel and Lodging | $876.54 |
| Education | $86.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $30,754.93 | 2021-2025 | |
| Astellas Pharma US INC | $12,757.28 | 2019-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $8,810.43 | 2019-2023 | |
| Organon LLC | $7,691.82 | 2021-2025 | Nexplanon, Jada System |
| Medtronic, INC. | $980.64 | 2022-2024 | Truclear |
| Hologic Sales and Service, LLC | $484.88 | 2019-2025 | Aptima |
| Applied Medical Resources Corporation | $427.86 | 2020 | |
| Myovant Sciences INC. | $277.27 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $241.43 | 2023-2025 | Myfembree |
| Amgen INC. | $218.42 | 2019-2025 | Evenity |
| Pfizer INC. | $217.09 | 2020-2025 | |
| Merck Sharp & Dohme LLC | $210.87 | 2019-2023 | Gardasil 9 |
| Exeltis, USA INC. | $187.76 | 2020-2024 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $183.23 | 2019-2025 | |
| Pacira Pharmaceuticals Incorporated | $120.10 | 2019 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $104.33 | 2024 | Aponvie |
| Exact Sciences Corporation | $101.64 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Dysis Medical, INC. | $100.02 | 2020 | |
| Coopersurgical, INC. | $89.51 | 2019-2024 | Wallach Cryosurgical Equipment, Paragard T 380a, Sos |
| Daiichi Sankyo INC. | $70.60 | 2020-2021 | |
| Astellas Pharma Global Development | $70.57 | 2023 | Veozah |
| Mallinckrodt Enterprises LLC | $51.64 | 2019 | |
| Millicent US INC | $49.91 | 2020 | |
| Channel Medsystems, INC. | $35.21 | 2023-2025 | |
| Mayne Pharma Commercial LLC | $32.37 | 2021-2022 | |
| Covidien LP | $31.32 | 2019 | |
| Evofem Biosciences, INC. | $30.75 | 2021 | |
| Agile Therapeutics, INC. | $27.44 | 2021-2023 | Twirla |
| Urovant Sciences INC | $26.57 | 2022 | |
| Avion Pharmaceuticals | $24.55 | 2020-2022 | |
| Baxter Healthcare | $24.38 | 2021 | |
| Inari Medical, INC. | $21.22 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Ironwood Pharmaceuticals, INC | $18.81 | 2024 | |
| Axonics, INC. | $18.37 | 2022 | |
| Mylan Pharmaceuticals INC. | $17.80 | 2021 | |
| Duchesnay USA Incorporated | $17.59 | 2019 | |
| Radius Health, INC. | $16.64 | 2019 | |
| Caldera Medical, INC | $14.15 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $13.84 | 2021 | |
| Medicem INC. | $11.59 | 2021 |
5 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Fleishman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.